MedTrace Logo

Efficacy Testing of Djulis-Buckwheat Drink on Cardiovascular Protection

NCT02825901 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-11-22

No results posted yet for this study

Summary

The purpose of the trial is to evaluate the effect of Djulis-Buckwheat drink on cardiovascular protection after ingesting for 8 weeks. In addition, the correlation between the supplement and the cardiovascular disease-related gene expression is evaluated. The results will be used for the application of functional products for cardiovascular protection.

Ninety subjects (age 30\~65) with Prehypertension or Hypertension stage 1 will be included and randomly allocated into 3 groups: Placebo, Djulis-Buckwheat and Buckwheat. The subjects will take sample (100 ml/day) for 8 weeks. Blood pressure will be measured on week 0, 1, 2, 4, 6 and 8. The blood biochemical parameters and gene expression analysis will be examined on week 2, 4, 6, 8 and 10 (the follow up).

Conditions

  • Prehypertension
  • Hypertension Stage 1

Interventions

DIETARY_SUPPLEMENT

Placebo

Ingest placebo drink 100ml/day for 8 weeks

DIETARY_SUPPLEMENT

Djulis-Buckwheat

Ingest Djulis-Buckwheat drink 100ml/day for 8 weeks

DIETARY_SUPPLEMENT

Buckwheat

Ingest Buckwheat drink 100ml/day for 8 weeks

Sponsors & Collaborators

  • Taipei Medical University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2020-01-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02825901 on ClinicalTrials.gov